These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33220820)

  • 21. [Botulinum toxin injection for refractory non-neurogenic overactive bladder. Systematic review].
    Henriet B; Roumeguère T
    Rev Med Brux; 2015; 36(1):29-37. PubMed ID: 25856969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overactive bladder - 18 years - Part II.
    Truzzi JC; Gomes CM; Bezerra CA; Plata IM; Campos J; Garrido GL; Almeida FG; Averbeck MA; Fornari A; Salazar A; Dell'Oro A; Cintra C; Sacomani CA; Tapia JP; Brambila E; Longo EM; Rocha FT; Coutinho F; Favre G; Garcia JA; Castano J; Reyes M; Leyton RE; Ferreira RS; Duran S; Lopez V; Reges R
    Int Braz J Urol; 2016; 42(2):199-214. PubMed ID: 27176185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Overactive bladder-which treatment when?].
    Pannek J
    Urologe A; 2017 Dec; 56(12):1532-1538. PubMed ID: 29043374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of BTX-A and neuromodulation in treating OAB with or without detrusor overactivity: a systematic review.
    Rachaneni S; Latthe P
    Int Urogynecol J; 2017 Jun; 28(6):805-816. PubMed ID: 28083714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinium toxin and idiopathic overactive bladder: Multicentric contempory management in Bourgogne].
    Schneider A; Tourlonias B; Cormier L; Mourey E; Koutlidis N; Delorme E; Pasquale J; Kermarec I; Foahom-Kamwa AD; Bonniaud V
    Prog Urol; 2018 Mar; 28(3):173-179. PubMed ID: 29329897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of botulinum toxin type A in non-neurogenic overactive bladder. Recommendations of the Working Group Urological Functional Diagnostics and Urology in Women].
    Bauer RM; Seif C; Bschleipfer T; Reitz A; Schultz-Lampel D;
    Urologe A; 2015 Mar; 54(3):368-72. PubMed ID: 25391442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review.
    Leong RK; De Wachter SG; van Kerrebroeck PE
    Urol Int; 2010; 84(3):245-53. PubMed ID: 20389150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Definition of botulinum toxin failure in neurogenic detrusor overactivity: Preliminary results of the DETOX survey].
    Peyronnet B; Sanson S; Amarenco G; Castel-Lacanal E; Chartier-Kastler E; Charvier K; Damphousse M; Denys P; de Seze M; Egon G; Even A; Forin V; Karsenty G; Kerdraon J; le Normand L; Loche CM; Manunta A; Mouracade P; Phe V; Previnaire JG; Ruffion A; Saussine C; Schurch B; Game X;
    Prog Urol; 2015 Dec; 25(17):1219-24. PubMed ID: 26318394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management].
    Hermieu JF; Ballanger P; Amarenco G; Chartier-Kastler E; Cosson M; Costa P; Fatton B; Deffieux X; Denys P; Gamé X; Haab F; Karsenty G; Le Normand L; Ruffion A; Saussine C
    Prog Urol; 2013 Dec; 23(17):1457-63. PubMed ID: 24286546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overactive bladder syndrome - management and treatment options.
    Arnold J; McLeod N; Thani-Gasalam R; Rashid P
    Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Standard pharmacological treatment and new therapies for overactive bladder].
    Del Popolo G; Mencarini M; Li Marzi V
    Urologia; 2012; 79(1):6-13. PubMed ID: 22344568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term outcomes of intradetrusor botulinum toxin A in multiple sclerosis patients].
    Gabay B; Maucort-Boulch D; Ruffion A; Scheiber Nogueira MC; Terrier JE
    Prog Urol; 2019 Mar; 29(3):156-165. PubMed ID: 30880066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urodynamic Outcomes in Children after Single and Multiple Injections for Overactive and Low Compliance Neurogenic Bladder Treated with Abobotulinum Toxin A.
    Naqvi S; Clothier J; Wright A; Garriboli M
    J Urol; 2020 Feb; 203(2):413-419. PubMed ID: 31518199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Two Treatment Modalities in Overactive Bladder: A Rapid Overview.
    Mirza AA; Alamoudi MA; Mirza AA; Alsubaie MA; Abuzenada MA
    Med Arch; 2022 Dec; 76(6):469-472. PubMed ID: 36937615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradetrusor injection of botulinum toxin A and sacral neuromodulation for neurogenic detrusor overactivity.
    Joussain C; Phé V; Even A; Chartier-Kastler E; Denys P
    Eur J Phys Rehabil Med; 2017 Dec; 53(6):991-997. PubMed ID: 29072045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy.
    Ridout AE; Yoong W
    J Obstet Gynaecol; 2010 Feb; 30(2):111-4. PubMed ID: 20143965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin injections in the management of non-neurogenic overactive bladders in children.
    Léon P; Jolly C; Binet A; Fiquet C; Vilette C; Lefebvre F; Bouché-Pillon-Persyn MA; Poli-Mérol ML
    J Pediatr Surg; 2014 Sep; 49(9):1424-8. PubMed ID: 25148752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin--a new therapeutic agent in girls with non-neurogenic overactive bladder--a case report and review of the literature.
    Kulik-Rechberger B; Piechuta L; Miotła P; Skorupski P; Rechberger T
    Ginekol Pol; 2010 Nov; 81(11):870-3. PubMed ID: 21361152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What to do if pills do not work for urge incontinence--still many questions and ambiguities].
    Koldewijn EL
    Ned Tijdschr Geneeskd; 2012; 156(33):A5099. PubMed ID: 22894810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
    Marcelissen TA; Rahnama'i MS; Snijkers A; Schurch B; De Vries P
    World J Urol; 2017 Feb; 35(2):307-311. PubMed ID: 27272312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.